← All companies

CSBR

Champions Oncology, Inc.

CSBR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$5.76

+0.50 +9.51%

Key statistics

from XBRL data in SEC filings

Market cap

$80.0M

Revenue (TTM)

$59.4M

Net income (TTM)

-$1.18M

EPS (TTM)

$-0.08

P/E ratio

—

Dividend yield

—

Free cash flow

-$5.04M

Cash

$4.87M

Total assets

$27.0M

Gross margin

—

52-week range

$5.22 – $8.74

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K Fiscal year ended 2026-04-30 Jul 27, 2026 8-K Results of operations (earnings release) Jul 27, 2026 8-K Director or officer change Mar 30, 2026 10-Q Quarter ended 2026-01-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 10-Q Quarter ended 2025-10-31 Dec 15, 2025 8-K Results of operations (earnings release) Dec 15, 2025 8-K Shareholder vote results Oct 16, 2025 10-Q Quarter ended 2025-07-31 Sep 15, 2025 8-K Results of operations (earnings release) Sep 15, 2025 10-K Fiscal year ended 2025-04-30 Jul 23, 2025 8-K Results of operations (earnings release) Jul 23, 2025 8-K Jul 21, 2025 10-Q Quarter ended 2025-01-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 11, 2025 10-Q Quarter ended 2024-10-31 Dec 16, 2024 8-K Results of operations (earnings release) Dec 11, 2024 8-K Shareholder vote results Oct 15, 2024 8-K Director or officer change Oct 3, 2024 10-Q Quarter ended 2024-07-31 Sep 13, 2024 8-K Results of operations (earnings release) Sep 11, 2024 10-K Fiscal year ended 2024-04-30 Jul 19, 2024 8-K Results of operations (earnings release) Jul 18, 2024 10-Q Quarter ended 2024-01-31 Mar 15, 2024 8-K Results of operations (earnings release) Mar 12, 2024 10-Q Quarter ended 2023-10-31 Dec 13, 2023 8-K Results of operations (earnings release) Dec 12, 2023 8-K Shareholder vote results Oct 19, 2023 8-K Director or officer change Oct 17, 2023 10-Q Quarter ended 2023-07-31 Sep 13, 2023 8-K Results of operations (earnings release) Sep 13, 2023 10-K Fiscal year ended 2023-04-30 Jul 24, 2023 8-K Results of operations (earnings release) Jul 24, 2023 8-K Regulation FD disclosure; Other events Apr 5, 2023 10-Q Quarter ended 2023-01-31 Mar 16, 2023 8-K Results of operations (earnings release) Mar 15, 2023 10-Q Quarter ended 2022-10-31 Dec 13, 2022 8-K Results of operations (earnings release) Dec 13, 2022 8-K Shareholder vote results Oct 20, 2022 10-Q Quarter ended 2022-07-31 Sep 12, 2022